Epoprostenol

CHEMBL1139 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

352.5 g/mol

LogP

2.9

Phase

4

This potent medication dilates blood vessels in the lungs and prevents blood clots from forming, helping to reduce the high blood pressure in the pulmonary circulation. It is used to treat severe pulmonary arterial hypertension.

Moleküler Ağırlık

352,5000 g/mol

LogP

2,90

TPSA

87,00 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Cardiovascular Disease Chronic Obstructive Pulmonary Disease Migraine Stroke Deep Vein Thrombosis / Pulmonary Embolism Type 2 Diabetes Hypertension Breast Cancer Heart Failure

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)O[C@H]2C[C@H]1O

InChI

InChI=1S/C20H32O5/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24)/b11-10+,15-8-/t14-,16+,17+,18+,19-/m0/s1

Molecular Formula

C20H32O5

HBD / HBA

3 / 5

Döndürülebilir Bağlar

10

Ağır Atomlar

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This potent medication dilates blood vessels in the lungs and prevents blood clots from forming, helping to reduce the high blood pressure in the pulmonary circulation. It is used to treat severe pulmonary arterial hypertension.

Yes, Epoprostenol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1139. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5282411. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Epoprostenol PillFYI'da

Yapı

Hızlı Veriler

Formül: C20H32O5
Eş Anlamlılar: 2

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.